Immunotherapy With or Without Radiation Therapy for Metastatic Urothelial Cancer

NCT04936230 · clinicaltrials.gov ↗

PHASE2

Phase

TERMINATED

Status

1

Enrollment

NIH

Sponsor class

Stopped Inadequate accrual rate

Conditions

Metastatic Urothelial Carcinoma
Platinum-Resistant Urothelial Carcinoma
Stage IV Bladder Cancer AJCC v8

Interventions

PROCEDURE: Biospecimen Collection
PROCEDURE: Bone Scan
PROCEDURE: Computed Tomography
PROCEDURE: Magnetic Resonance Imaging
BIOLOGICAL: Pembrolizumab
PROCEDURE: Positron Emission Tomography
OTHER: Questionnaire Administration
RADIATION: Stereotactic Body Radiation Therapy

Sponsor

National Cancer Institute (NCI)